Literature DB >> 2838956

A recombinant murine retrovirus expressing v-rel is cytopathic.

R C Schwartz1, O N Witte.   

Abstract

A murine retrovirus that expresses the avian v-rel oncogene was constructed. NIH 3T3 cells transfected with this construct expressed v-rel-specific RNA and a 59-kDa protein serologically identical to avian v-rel. The protein expressed from the recombinant retrovirus retained the associated protein kinase activity observed in avian systems. While the detection of v-rel RNA sequences in infected cells verified the infectivity of the retrovirus, the retrovirus did not transform either murine fibroblasts or bone marrow cells. Rather, a cytopathic effect was observed in murine fibroblasts and a pre-B lymphoid cell line that were infected with the murine retrovirus. Growth curves of these infected cells revealed cell death or diminished growth rate in all cases.

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 2838956     DOI: 10.1016/0042-6822(88)90671-x

Source DB:  PubMed          Journal:  Virology        ISSN: 0042-6822            Impact factor:   3.616


  18 in total

1.  Mutational analysis of the v-Rel dimerization interface reveals a critical role for v-Rel homodimers in transformation.

Authors:  Andrew S Liss; Henry R Bose
Journal:  J Virol       Date:  2002-05       Impact factor: 5.103

2.  Rel-dependent induction of A1 transcription is required to protect B cells from antigen receptor ligation-induced apoptosis.

Authors:  R J Grumont; I J Rourke; S Gerondakis
Journal:  Genes Dev       Date:  1999-02-15       Impact factor: 11.361

3.  Interaction of the v-rel protein with an NF-kappa B DNA binding site.

Authors:  N Kabrun; J W Hodgson; M Doemer; G Mak; B R Franza; P J Enrietto
Journal:  Proc Natl Acad Sci U S A       Date:  1991-03-01       Impact factor: 11.205

4.  The transforming domain alone of the latent membrane protein of Epstein-Barr virus is toxic to cells when expressed at high levels.

Authors:  W Hammerschmidt; B Sugden; V R Baichwal
Journal:  J Virol       Date:  1989-06       Impact factor: 5.103

5.  Transactivation of gene expression by nuclear and cytoplasmic rel proteins.

Authors:  M Hannink; H M Temin
Journal:  Mol Cell Biol       Date:  1989-10       Impact factor: 4.272

6.  Evolution of the oncogenic potential of v-rel: rel-induced expression of immunoregulatory receptors correlates with tumor development and in vitro transformation.

Authors:  J Nehyba; R Hrdlicková; E H Humphries
Journal:  J Virol       Date:  1994-04       Impact factor: 5.103

7.  Rel/NF-kappaB represses bcl-2 transcription in pro-B lymphocytes.

Authors:  U S Sohur; M N Dixit; C L Chen; M W Byrom; L A Kerr
Journal:  Gene Expr       Date:  1999

8.  The mouse c-rel protein has an N-terminal regulatory domain and a C-terminal transcriptional transactivation domain.

Authors:  P Bull; K L Morley; M F Hoekstra; T Hunter; I M Verma
Journal:  Mol Cell Biol       Date:  1990-10       Impact factor: 4.272

9.  The v-rel oncogene promotes malignant T-cell leukemia/lymphoma in transgenic mice.

Authors:  D Carrasco; C A Rizzo; K Dorfman; R Bravo
Journal:  EMBO J       Date:  1996-07-15       Impact factor: 11.598

10.  v-rel induces expression of three avian immunoregulatory surface receptors more efficiently than c-rel.

Authors:  R Hrdlicková; J Nehyba; E H Humphries
Journal:  J Virol       Date:  1994-01       Impact factor: 5.103

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.